Sherman Asset Management, Inc. Cytokinetics Inc Transaction History
Sherman Asset Management, Inc.
- $113 Billion
- Q2 2025
A detailed history of Sherman Asset Management, Inc. transactions in Cytokinetics Inc stock. As of the latest transaction made, Sherman Asset Management, Inc. holds 142 shares of CYTK stock, worth $8,427. This represents 0.0% of its overall portfolio holdings.
Number of Shares
142
Previous 142
-0.0%
Holding current value
$8,427
Previous $5.71 Million
17.8%
% of portfolio
0.0%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding CYTK
# of Institutions
383Shares Held
129MCall Options Held
3.62MPut Options Held
1.14M-
T. Rowe Price Investment Management, Inc. Baltimore, MD17.6MShares$1.04 Billion0.37% of portfolio
-
Black Rock Inc. New York, NY14.7MShares$871 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$711 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA7.83MShares$465 Million0.05% of portfolio
-
State Street Corp Boston, MA6.37MShares$378 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $5.59B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...